Infectious Diseases Physician @GC_Health. Panathinaikos supporter and football lover. Tweets are my own.
Brisbane, Queensland
Joined June 2011
- Tweets80
- Following426
- Followers217
- Likes11.1K
Interested in hearing about any cases that anyone has encountered with the pathogen Photorhabdus asymbiotica in the last decade. Please comment if you have! #IDTwitter
1
137
Peter Simos retweeted
“Due to increasing fluoroquinolone resistance, trimethoprim-sulfamethoxazole will be recommended as the preferred oral empiric therapy for non-severe Salmonella disease.”
@SazaliBasri @HanzHc
This is interesting
TMP-SMX
contagionlive.com/view/risin…
Peter Simos retweeted
People with baseline high plama HIV-1 RNA and low CD4 counts have an increased risk of RV, LLV and virol failure with every ART, also when starting INSTI and specifically DTG. These are lifelong determinants of non virol suppression #RESPOND.
academic.oup.com/cid/advance…
Peter Simos retweeted
🆕️🔥🔥ICYMI 🔴 @CIDJournal
@VanceFowler5
The 2023 Duke-ISCVID Criteria for Infective Endocarditis: Updating the Modified Duke Criteria
Follow me+Like it +Retweet it +DM me & I'll send you a link for full text✔️ #IDTwitter #IEwikiguidelines
academic.oup.com/cid/advance…
Peter Simos retweeted
More isolates with ⬆️ voriconzaole MIC values in 2020-21. No difference in azole resistance between North QLD vs Southeast QLD acquisition 🇦🇺@burcucella @peter_simos
Aspergillus species causing invasive fungal disease in Queensland, Australia @SpringerMicBio #Mycopathologia #OpenAccess
link.springer.com/article/10…
Peter Simos retweeted
⛔️US FDA⛔️
Atovaquone oral suspension USP, 750 mg/5 mL by Camber Pharmaceuticals: Recall - Due to potential Bacillus cereus contamination in the product #IDTwitter fda.gov/safety/recalls-marke…
Peter Simos retweeted
🔥🔥 Now launched! Online summaries of the Australasian consensus guidelines for the use of antifungal agents in haem/onc. New: Antifungal stewardship, AND a chapter dedicated to supporting HCWs managing patients at risk for invasive fungal infections! Links to the full text are also available. #IMJ
onlinelibrary.wiley.com/jour… @NCICancer
For MSSA prosthetic valve endocarditis what is your standard antimicrobial regimen?
14%Anti-staph penicillin
14%Cefazolin
29%Anti-staph pen+RIF
43%Anti-staph pen+RIF+Gent
7 votes • Final results 1
Peter Simos retweeted
💥Just Out
ACTT-4 Trial👉First Double Placebo-Controlled Double-Blind Randomized-Stratified Head-to-Head
#DEXAMETHASONE vs #BARICITINIB for hospitalized pts w/#COVID19 Low/High-Flow/NIV
Relevant👉Patient Care/Public Health/Guidelines
Our results
👇
bit.ly/3Gac9w7
🧵1/4
Excited for the return of the puscast. Such a fantastic initiative.
On the first episode of the Infectious Disease Puscast, Daniel and Sara bring Marc Crislip’s well known Puscast back to life, and present a review of the infectious disease literature for the previous two weeks, 4/13 – 4/27/22 bit.ly/3OTRe4p #puscast
Check out our study on clinical prediction scores for IE in Staphylococcus aureus bacteraemia. Time to positive culture (TTP) significantly improved all scores. Findings support the omission of echocardiography in patients with a negative VIRTSA+ score academic.oup.com/jac/advance…
Peter Simos retweeted
How close are we to the approval of the first oral #Carbapenem?
Dear antibiotic stewards,
Excited or terrified?
PDUFA JUN 27, stay tuned! #IDTwitter #MedEd #TwitteRx #MedTwitter
🔥ADAPT-PO RCT🔥 @NEJM
Oral Tebipenem Pivoxil(oral carbapenem) Hydrobromide Vs Ertapenem in Complicated Urinary Tract Infection #IDTwitter #MedEd #TwitteRx
nejm.org/doi/full/10.1056/NE…
Peter Simos retweeted
Unfortunately Sotrovimab at current dosing is not effective for ba2 as per the fda. Will be looking at this for now - however our supplies of paxlovid are good, and there is still a need for these drugs. If you are at risk please get tested
fda.gov/drugs/drug-safety-an…
Love the work from the Danish group with Chamat-Hedemand and colleagues on the risk of IE by streptococcal species. #IDtwitter #medtwitter
1
5